METHENAMINE, SODIUM SALICYLATE

N/A

Manufactured by Aurobindo Pharma Limited

348 FDA adverse event reports analyzed

Last updated: 2026-04-15

About METHENAMINE, SODIUM SALICYLATE

METHENAMINE, SODIUM SALICYLATE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Aurobindo Pharma Limited. The most commonly reported adverse reactions for METHENAMINE, SODIUM SALICYLATE include NAUSEA, HEADACHE, MALAISE, URINARY TRACT INFECTION, FATIGUE. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for METHENAMINE, SODIUM SALICYLATE.

Top Adverse Reactions

NAUSEA13 reports
HEADACHE11 reports
MALAISE11 reports
URINARY TRACT INFECTION11 reports
FATIGUE10 reports
PAIN9 reports
CYSTITIS8 reports
INSOMNIA7 reports
ACUTE KIDNEY INJURY6 reports
BRONCHITIS6 reports
DEATH6 reports
DIARRHOEA6 reports
DYSPNOEA6 reports
PNEUMONIA6 reports
ARTHRALGIA5 reports
BACK PAIN5 reports
CHRONIC KIDNEY DISEASE5 reports
DIZZINESS5 reports
WEIGHT INCREASED5 reports
ABDOMINAL PAIN UPPER4 reports
ALOPECIA4 reports
ANXIETY4 reports
ASTHENIA4 reports
CHEST PAIN4 reports
CONSTIPATION4 reports
COUGH4 reports
DECREASED APPETITE4 reports
DRUG INEFFECTIVE4 reports
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION4 reports
MUSCLE SPASMS4 reports
PAIN IN EXTREMITY4 reports
PYREXIA4 reports
SWELLING4 reports
TREMOR4 reports
VOMITING4 reports
BLOOD GLUCOSE INCREASED3 reports
CARDIAC DISORDER3 reports
CHILLS3 reports
DEHYDRATION3 reports
DRY MOUTH3 reports
DYSURIA3 reports
GASTROOESOPHAGEAL REFLUX DISEASE3 reports
INFECTION3 reports
NASOPHARYNGITIS3 reports
PARAESTHESIA3 reports
SEPSIS3 reports
SINUSITIS3 reports
WEIGHT DECREASED3 reports
ABDOMINAL DISCOMFORT2 reports
ADVERSE DRUG REACTION2 reports
ANAEMIA2 reports
BLOOD IRON DECREASED2 reports
BLOOD PRESSURE DECREASED2 reports
BLOOD PRESSURE INCREASED2 reports
BONE PAIN2 reports
BRUXISM2 reports
BURNING SENSATION2 reports
CARDIOMEGALY2 reports
DEPRESSION2 reports
DISCOMFORT2 reports
DYSPHAGIA2 reports
EAR INFECTION2 reports
ERYTHEMA2 reports
FALL2 reports
FEELING ABNORMAL2 reports
FEELING HOT2 reports
FUNGAL INFECTION2 reports
GASTRITIS2 reports
GASTROENTERITIS VIRAL2 reports
HAEMOGLOBIN DECREASED2 reports
HYPERSENSITIVITY2 reports
HYPOAESTHESIA2 reports
ILLNESS2 reports
INFLUENZA2 reports
INFUSION SITE PAIN2 reports
INJECTION SITE PAIN2 reports
INTENTIONAL DOSE OMISSION2 reports
JOINT SWELLING2 reports
KIDNEY INFECTION2 reports
LOWER LIMB FRACTURE2 reports
MEMORY IMPAIRMENT2 reports
MIGRAINE2 reports
MYALGIA2 reports
NEUROPATHY PERIPHERAL2 reports
OVERDOSE2 reports
PANCREATITIS2 reports
PRODUCT ADMINISTRATION INTERRUPTED2 reports
PULMONARY FIBROSIS2 reports
RASH2 reports
RENAL FAILURE2 reports
SEIZURE2 reports
SPINAL PAIN2 reports
STATUS EPILEPTICUS2 reports
SURGERY2 reports
SYNCOPE2 reports
THROAT IRRITATION2 reports
UNDERDOSE2 reports
UPPER RESPIRATORY TRACT INFECTION2 reports
URINARY TRACT DISORDER2 reports
VITAMIN D DECREASED2 reports

Report Outcomes

Out of 102 classified reports for METHENAMINE, SODIUM SALICYLATE:

Serious 60.8%Non-Serious 39.2%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female92 (94.8%)
Male5 (5.2%)

Reports by Age

Age 495 reports
Age 585 reports
Age 643 reports
Age 773 reports
Age 813 reports
Age 252 reports
Age 292 reports
Age 452 reports
Age 522 reports
Age 612 reports
Age 682 reports
Age 762 reports
Age 191 reports
Age 271 reports
Age 281 reports
Age 331 reports
Age 341 reports
Age 421 reports
Age 441 reports
Age 481 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with METHENAMINE, SODIUM SALICYLATE?

This profile reflects 348 FDA FAERS reports that mention METHENAMINE, SODIUM SALICYLATE. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for METHENAMINE, SODIUM SALICYLATE?

Frequently reported terms in FAERS include NAUSEA, HEADACHE, MALAISE, URINARY TRACT INFECTION, FATIGUE, PAIN. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures METHENAMINE, SODIUM SALICYLATE?

Labeling and FAERS entries often list Aurobindo Pharma Limited in connection with METHENAMINE, SODIUM SALICYLATE. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.